Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 899

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 899
---
3.24Export Controls and Economic SanctionsA-24Section 3.25Health Care Regulatory MattersA-24Section 3.26Data Privacy and SecurityA-26Section 3.27No Other Representations or WarrantiesA-27A-i

#### TABLE OF CONTENTS(Continued)PageARTICLE IVREPRESENTATIONS AND WARRANTIES OF PARENT AND THE MERGER SUBSA-27Section 4.1Organization, Standing and PowerA-27Section 4.2AuthorityA-28Section 4.3Capital StockA-28Section 4.4No Conflict; Consents and ApprovalsA-29Section 4.5SEC Reports; Financial StatementsA-29Section 4.6No Undisclosed LiabilitiesA-31Section 4.7BrokersA-31Section 4.8Merger SubA-31Section 4.9LitigationA-31Section 4.10Available FundsA-31Section 4.11No Other Representations or WarrantiesA-31ARTICLE VCOVENANTSA-32Section 5.1Conduct of Business of the CompanyA-32Section 5.2Conduct of Parent and Merger Subs Pending the ClosingA-34Section 5.3No Control of Other Party’s BusinessA-35Section 5.4Solicitation of Transactions; RecommendationA-35Section 5.5Access to Information; ConfidentialityA-37Section 5.6Further Action; EffortsA-38Section 5.7Registration Statement; Proxy StatementA-38Section 5.8Takeover LawsA-40Section 5.9Notification of Certain MattersA-40Section 5.10Indemnification, Exculpation and InsuranceA-41Section 5.11Public AnnouncementsA-42Section 5.12Section 16 MattersA-42Section 5.13Listing of Parent Common StockA-43Section 5.14DeregistrationA-43Section 5.15Obligations of the Merger SubsA-43Section 5.16Stockholder LitigationA-43Section 5.17Company Stock PlansA-43Section 5.18Tax Treatment of MergersA-43Section 5.19Permitted Asset DispositionA-44ARTICLE VICONDITIONS PRECEDENTA-44Section 6.1Conditions to Each Party’s Obligation to Effect the